IL82213A - Method for the production of an ossein hydroxyapatite compound - Google Patents

Method for the production of an ossein hydroxyapatite compound

Info

Publication number
IL82213A
IL82213A IL82213A IL8221387A IL82213A IL 82213 A IL82213 A IL 82213A IL 82213 A IL82213 A IL 82213A IL 8221387 A IL8221387 A IL 8221387A IL 82213 A IL82213 A IL 82213A
Authority
IL
Israel
Prior art keywords
production
hydroxyapatite compound
ossein
ossein hydroxyapatite
compound
Prior art date
Application number
IL82213A
Other languages
English (en)
Other versions
IL82213A0 (en
Original Assignee
Robapharm Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robapharm Ag filed Critical Robapharm Ag
Publication of IL82213A0 publication Critical patent/IL82213A0/xx
Publication of IL82213A publication Critical patent/IL82213A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/84—Bones; tendons; teeth; cartilage

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Steroid Compounds (AREA)
IL82213A 1986-08-05 1987-04-15 Method for the production of an ossein hydroxyapatite compound IL82213A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3626414A DE3626414C2 (de) 1986-08-05 1986-08-05 Präparat zur Stimulierung von Chondrocyten und Osteoblasten (Ossein-Hydroxyapatit-Komplex), Verfahren zu seiner Herstellung und dieses enthaltende Arzneimittel

Publications (2)

Publication Number Publication Date
IL82213A0 IL82213A0 (en) 1987-10-30
IL82213A true IL82213A (en) 1991-08-16

Family

ID=6306689

Family Applications (1)

Application Number Title Priority Date Filing Date
IL82213A IL82213A (en) 1986-08-05 1987-04-15 Method for the production of an ossein hydroxyapatite compound

Country Status (20)

Country Link
US (1) US4919931A (xx)
EP (1) EP0255565B1 (xx)
JP (1) JPS6344527A (xx)
KR (2) KR880002897A (xx)
CN (1) CN1028237C (xx)
AR (1) AR242589A1 (xx)
AT (1) ATE77239T1 (xx)
AU (1) AU604014B2 (xx)
CA (1) CA1289878C (xx)
DE (2) DE3626414C2 (xx)
DK (1) DK175488B1 (xx)
ES (1) ES2041647T3 (xx)
FI (1) FI91877C (xx)
GR (1) GR3005579T3 (xx)
HU (1) HU205373B (xx)
IE (1) IE59916B1 (xx)
IL (1) IL82213A (xx)
NO (1) NO173786C (xx)
PT (1) PT84693B (xx)
ZA (1) ZA872701B (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4859467A (en) * 1986-09-25 1989-08-22 Colgate-Palmotive Company Sustained release fluoride composition
US4861590A (en) * 1986-09-25 1989-08-29 Colgate-Palmolive Company Sustained release fluoride and calcium composition
JPH02149618A (ja) * 1988-11-30 1990-06-08 Kobe Steel Ltd 加工性に優れた高強度熱延鋼板の製造方法
CN1045719C (zh) * 1993-04-10 1999-10-20 北京市西城区华新生化技术研究所 口服接骨和治骨质疏松液
EP0635518B1 (en) * 1993-07-23 2003-10-08 Kato, Yukio, Prof. New chondrocyte protein
PT777491E (pt) * 1994-08-23 2005-01-31 Stoess & Co Gelatine Utilizacao de colagenio hidrolisado, de sabor neutro e agente que o contem
US5788941A (en) * 1996-01-31 1998-08-04 Steris Corporation Method of sterilization of bone tussue
JPH09238291A (ja) * 1996-02-29 1997-09-09 Sony Corp メニュー操作方法及び電子機器及びテレビジョン受像機
NL1020729C2 (nl) * 2002-05-31 2003-12-02 Gelatine Smits Beheer B V Calciumbevattende samenstelling, werkwijze voor het bereiden daarvan, en farmaceutisch preparaat op basis van de samenstelling.
CN1212126C (zh) * 2002-07-09 2005-07-27 中国科学院长春应用化学研究所 纳米羟基磷灰石补钙剂
JP4369969B2 (ja) * 2007-10-26 2009-11-25 株式会社アールビーエス 生体適合性材料並びにその製造方法
US9347081B2 (en) 2011-04-19 2016-05-24 Bioiberica, S.A. Cartilage product
RU2478394C1 (ru) * 2011-11-23 2013-04-10 Федеральное государственное бюджетное учреждение "Российский научный центр "Восстановительная травматология и ортопедия" имени академика Г.А. Илизарова" Министерства здравоохранения и социального развития Российской Федерации Биоматериал для возмещения дефектов костей и способ его получения
AU2014316766B2 (en) 2013-09-05 2019-10-10 Waitaki Biosciences High osteocalcin microcrystalline hydroxyapatite for calcium supplement

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE894895C (de) * 1950-03-06 1953-10-29 Albert Dr Reissner Verfahren zur Herstellung eines Praeparates zur Anregung der Zahnerhaltung
USRE28093E (en) * 1962-02-28 1974-07-30 Wound-healing cartilage powder
US3400199A (en) * 1965-02-26 1968-09-03 Leslie L. Balassa Wound-healing cartilage powder
BE650626A (xx) * 1962-02-28 1900-01-01
DE2425266A1 (de) * 1974-05-24 1975-11-27 Lothar Tischmann Zum einnehmen bestimmtes naehr- und heilmittel aus tierischer knochen-substanz und verfahren zu seiner herstellung
DE2840064C2 (de) * 1978-09-14 1989-09-21 Hans Dr.med. Dr.med.dent. 8000 München Scheicher Verfahren zur Herstellung von Knochenkontaktschichten
US4232425A (en) * 1980-01-15 1980-11-11 Darling & Company Method of producing stabilized bone
US4455256A (en) * 1981-05-05 1984-06-19 The Regents Of The University Of California Bone morphogenetic protein
US4294753A (en) * 1980-08-04 1981-10-13 The Regents Of The University Of California Bone morphogenetic protein process
ZA816771B (en) * 1980-10-07 1982-10-27 Lensfield Prod Ltd Protein production
US4444752A (en) * 1982-09-13 1984-04-24 Lescarden Ltd. Method for treating progressive systemic sclerosis
US4436720A (en) * 1983-03-04 1984-03-13 Pakhomov Gennady N Granulated treatment-and-prophylactic dental preparation possessing anticarious effect
NZ210699A (en) * 1984-01-04 1989-06-28 Int Genetic Eng Isolation of an osteogenic protein of the p3 immunologically related family
DE3409372A1 (de) * 1984-03-14 1985-09-19 Dr. Ruhland Nachf. GmbH, 8425 Neustadt Material zum vitalisieren von implantatoberflaechen
DE3422466C1 (de) * 1984-06-16 1986-03-20 Lothar 6750 Kaiserslautern Tischmann Verfahren zum Herstellen eines eßbaren, proteinhaltigen Knochenmehlpräparates aus frischen Tierknochen
US4620327A (en) * 1984-07-05 1986-11-04 Caplan Arnold I Process of adapting soluble bone protein for use in stimulating osteoinduction

Also Published As

Publication number Publication date
JPS6344527A (ja) 1988-02-25
CN1028237C (zh) 1995-04-19
IE59916B1 (en) 1994-04-20
KR960009651B1 (en) 1996-07-23
IE870983L (en) 1988-02-05
DK196387A (da) 1988-02-06
NO871599D0 (no) 1987-04-15
AR242589A1 (es) 1993-04-30
NO871599L (no) 1988-02-08
FI871670A0 (fi) 1987-04-15
GR3005579T3 (xx) 1993-06-07
JPH0558606B2 (xx) 1993-08-27
FI91877B (fi) 1994-05-13
KR880002897A (ko) 1988-05-12
PT84693A (en) 1987-05-01
CA1289878C (en) 1991-10-01
FI91877C (fi) 1994-08-25
NO173786B (no) 1993-10-25
HU205373B (en) 1992-04-28
ES2041647T3 (es) 1993-12-01
KR880002534A (ko) 1988-05-09
DE3626414C2 (de) 1994-11-10
NO173786C (no) 1994-02-02
ATE77239T1 (de) 1992-07-15
EP0255565A2 (en) 1988-02-10
DK175488B1 (da) 2004-11-08
DK196387D0 (da) 1987-04-15
IL82213A0 (en) 1987-10-30
AU604014B2 (en) 1990-12-06
EP0255565B1 (en) 1992-06-17
DE3779829D1 (de) 1992-07-23
DE3626414A1 (de) 1988-02-11
EP0255565A3 (en) 1990-01-31
CN87102744A (zh) 1988-02-17
AU7157787A (en) 1988-02-11
US4919931A (en) 1990-04-24
DE3779829T2 (de) 1993-01-14
FI871670A (fi) 1988-02-06
PT84693B (pt) 1990-06-29
ZA872701B (en) 1987-11-25
HUT44047A (en) 1988-01-28

Similar Documents

Publication Publication Date Title
EP0202908A3 (en) Method for the production of endosseous implants
PL268098A1 (en) The method of manufacture of new derivatives of naphtiridin- or quinolincarboxy acid
AR242585A1 (es) Procedimiento para la produccion de polideoxi-ribonucleotido defibrotide
GB2185013B (en) Process for the production of 3-phenyl-4-cyanopyrroles
IL82213A (en) Method for the production of an ossein hydroxyapatite compound
IL79020A0 (en) Process for the manufacture of monopotassium phosphate
PL266231A1 (en) The method of manufacture of new derivatives of dilnidropyridine
CS96488A2 (en) Method of arylpiperazinyl-alkylenphenyl-heterocyclic compounds production
DE3466983D1 (en) Method for the preparation of 2-amino-alkylpyridines
PT84998A (en) Process for the manufacture of aralkylimidazole derivatives
DE3465473D1 (en) Method for the preparation of 2-chlorbenzoxazoles
PL266478A1 (en) Procedure for the production of mercaptoacyloproline
AU596650B2 (en) Process for the manufacture of n-sulfonylmethyl)-formamides
CS850787A2 (en) Method of substituted 1-phenoxy-3-amino-2-propanols production
DE3563744D1 (en) Method for the production of solid cyanuric chloride
DE3461081D1 (en) Method for the preparation of benzenamines
EP0255650A3 (en) Method for the production of indanes
EP0267501A3 (en) Method for the continuous production of aliphatic compounds containing carbalkoxy groups
IL84335A0 (en) Process for the production of laser cathodes
PT80222A (en) Process for the manufacture of novel substituted benzodioxole derivatives
GB8729133D0 (en) Method for production of 1-valine
EP0260472A3 (en) Method for the production of cycloaliphatic ketones
EP0267383A3 (en) Process for the manufacturing of cycloheptanone process for the manufacturing of cycloheptanone
DE3560104D1 (en) Process for the production of 2-methyl-2-alkenals from dihydropyranes
PL268619A1 (en) The method of manufacture of new heterocyclic components

Legal Events

Date Code Title Description
EXP Patent expired